nms-labs documents

Health & Medicine K2 and Beyond: A Synthetic Cannabinoid Primer

Health & Medicine The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry

Health & Medicine The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

Health & Medicine Developments in Toxicology Support for the DRE Community

Health & Medicine Pharmacodynamics and Pharmacokinetics of Synthetic Cannabinoids

Health & Medicine Increasing Diversity of Chemicals in Synthetic Stimulant and Cathinone Cases

Health & Medicine Oral Fluid as a Chemical Test for the DRE Program

Health & Medicine Trends Report on Changes in the Designer Drug Market: Spring 2012

Health & Medicine K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis

Health & Medicine New Highs: Salvia and K 2 - Solutions for the DRE

Health & Medicine NMS Labs introduction

Health & Medicine Designer Drugs Testing Solutions for Employers

Health & Medicine Salvia: Effects, Legal Status and Analysis

Health & Medicine Testing for BPA and other EDCs

Health & Medicine NMS Labs Dinner Presentation by Dr. Andrea Gore 5-27-10

Documents Julie Ruth Resume January 2017